The global automated endoscopy reprocessor market size was valued at US$ 845.3 million in 2017 and is expected to witness a robust CAGR of 6.7% over the forecast period (2018–2026).

Mergers and acquisitions by market players are expected to drive the neurodegenerative disease treatment market growth.

Strategic collaboration to develop advance smart card technology to provide value added services in healthcare is expected propel growth of the market.

Increasing number of awareness campaigns for weight management is expected to be a major driver for Orlistat market growth

Increasing number of samples to be analyzed is increasing the demand for faster analytical methods that are capable of providing better information for decision making.

Drug resistance to antifungal medications is widely witnessed during treatment of aspergillosis infections, which is expected to restrain growth of the acute invasive aspergillosis treatment market

lack of proper reimbursement for the orthodontic procedures and products due to limited insurance coverage is expected to hamper growth of dental braces market

Transcatheter embolization is a less invasive and highly efficient way to control bleeding as compared to open invasive surgical procedures.

Research and development by pharmaceutical and biotech companies to drive growth of the global lab automation market.

New drug approvals are expected to boost the dextrose injection market growth.

Nanotechnology is an emerging field of science that involves atomic or molecular level manipulation of matter.

Large number of undiagnosed patient’s and revised diagnostic guidelines to propel growth for Alzheimer’s drugs market

North America to dominate the market for cell line development due to high investment in research by pharmaceutical companies to develop novel product

Increasing prevalence of naïve infectious chronic diseases such as chronic kidney disease around the globe is the major factor propelling demand for medical membrane.